What's Happening with CVS
CVS Health Corp (CVS) is scheduled to report Quarter 2 numbers before the market open on August 5. Analysts forecast earnings of $0.81 per share for the quarter. During the same period last year the company earned $0.79, and the stock is down -15.3% on the year.
CVS was recently trading at $62.92 down $14.11 from its 12-month high and $10.88 above its 12-month low. InvestorsObserver gives CVS a 46 long-term technical score and a 70 short-term technical score. The stock has recent support above $60.23 and recent resistance below $65.1. Of the 17 analysts who cover the stock 10 rate it Strong Buy, 2 rate it Buy, 5 rate it Hold, 0 rate it Sell, and 0 rate it Strong Sell, CVS gets an overall score of 65 from InvestorsObserver.
CVS has shown annual earnings growth of 10.62% over the last five years, and looking ahead analysts expect the company to grow profits 5.90% per annum the next five years. Last quarter the company posted better than expected EPS and this quarter the street expects $1.69 EPS. CVS is currently trading at $0.81 with an average price target of $78.78